• Facilities
    • Cork, Ireland
    • Cramlington, UK
    • Deeside, UK
    • Newcastle Biosphere, UK
    • North Carolina, US
    • Wisconsin, US
  • Sustainability
    • Environmental sustainability
  • Molecule Lifecycle
    • Discovery
    • Preclinical
    • Phase One
    • Phase Two
    • Phase Three
    • Launch
  • About Us
    • Our Heritage
    • Vision and Values
    • HSE
    • Quality and Regulatory
    • Technology and Innovation Programme
    • PDMO
    • Executive Team
    • Community
  • Careers Hub
    • Our Vacancies
    • Life at Sterling
    • STEM
    • Early Career Paths at Sterling
    • Professional Career Paths at Sterling
    • Meet our People
    • Our Locations
  • News and Events
    • News
    • Events
  • Contact
Sterling Pharma Solutions Logo
Sterling Pharma Solutions Logo
✕
  • Dedicated Scientists
    • Full Time Equivalent (FTE)
    • Extended Benchâ„¢
  • Chemistry Services
    • Drug Discovery
    • Early Scale Up
    • Analytical Services
    • Radiolabelling
  • Small Molecules
    • Small Molecule Services
      • API Development
      • API Manufacturing
      • CMC Services
      • Solid State Chemistry
      • Milling/Micronisation
    • Small Molecule Technologies
      • Hazard Evaluation
      • Chiral Chemistry
      • Hazardous Chemistry
      • Diazomethane
      • Continuous | Flow
      • Biocatalysis
      • High Potency APIs
      • Controlled Substances
  • Peptides
  • ADCs
    • ADC Development
    • ADC Analytical Services
    • Mass Spectrometry
    • ADC Clinical Manufacturing
    • Linker Payloads
  • Knowledge Hub
  • Home
  • Dedicated Scientists
    • Full Time Equivalent (FTE)
    • Extended Benchâ„¢
  • Chemistry Services
    • Drug Discovery
    • Early Scale Up
    • Analytical Services
    • Radiolabelling
  • Small Molecules
    • Small Molecule Services
      • API Development
      • API Manufacturing
      • CMC Services
      • Solid State Chemistry
      • Milling/Micronisation
    • Small Molecule Technologies
      • Hazard Evaluation
      • Chiral Chemistry
      • Hazardous Chemistry
      • Diazomethane
      • Continuous | Flow
      • Biocatalysis
      • High Potency APIs
      • Controlled Substances
  • Peptides
  • ADCs
    • ADC Development
    • ADC Analytical Services
    • Mass Spectrometry
    • ADC Clinical Manufacturing
    • Linker Payloads
  • Molecule Lifecycle
  • Knowledge Hub
  • About Us
    • Our Heritage
    • HSE
    • Quality and Regulatory
    • Technology and Innovation Programme
    • PDMO
    • Executive Team
    • Community
  • Facilities
  • Sustainability
  • Careers Hub
    • Our Vacancies
    • Life at Sterling
    • STEM
    • Early Career Paths at Sterling
    • Professional Career Paths at Sterling
    • Vision and Values
    • Meet our People
    • Our Locations
  • News and Events
  • Contact
Home - Knowledge Hub - Technologies

Technologies

All Biocatalysis Flow Chemistry Controlled Substances Hazardous Chemistry HPAPI

All articles

Greg Holgate - Biocatalysis Chemist News
Blog2 min read
Biocatalysis Chemist receives Newcastle University alumni achievement award Read more
Biocatalysis
News2 min read
Biocatalysis partnership judged outstanding Read more
Making sense of controlled substances download preview Drug Discovery
Making Sense of5 min read
Making sense of controlled substances

Navigating complex regulatory requirements with the right outsourced partner.

Read more
Biocatalysis
Article2 min read
Sterling announces exclusive partnership with the University of Manchester to develop novel route to newly approved COVID-19 therapy, Molnupiravir Read more
Flow Chemistry
News2 min read
Sterling establishes centre of excellence in continuous flow chemistry at Dudley, UK facility Read more
Flow Chemistry
News2 min read
Sterling appoints Professor Ian Baxendale to spearhead flow chemistry development team Read more
HPAPI
Infographic1 min read
[Infographic] Unlocking the Potential of Highly Potent APIs Read more
Picture of a scientist using biocatalysis equipment in the labs at Sterling's Cramlington, UK facility Biocatalysis
Webinar13 min read
An up-close look at biocatalysis: Accelerating synthesis using nature's catalysts Read more
Hazardous Chemistry
Making Sense of5 min read
Making sense of hazard evaluation Read more
Next Page »

Explore more

All ADCs API Development API Manufacturing Analytical Services Drug Discovery Facilities News PDMO People Peptides Sustainability Technologies

Sign up for updates

Be the first to see the latest articles and updates from industry leaders, delivered straight to your inbox

This field is for validation purposes and should be left unchanged.
Name(Required)
This field is hidden when viewing the form
Please click here for our privacy policy
Sterling Pharma Solutions Footer LogoService. Passion. Science.
linkedin iconfacebook iconyoutube icon
Enquire now
  • Privacy Policy
  • Cookie Policy
  • Manage Cookies
  • Website Terms and Conditions
  • Gender Pay Gap
  • Modern Slavery Policy

PDMO® is registered in the U.S. Patent and Trademark Office.

PDMO® is a registered trademark of Sterling Pharma Solutions Limited (EUIPO and UKIPO). All rights reserved.

Sterling Pharma Solutions Limited. Registration number: 05712796. Registered office address: Dudley Lane, Dudley, Cramlington, NE23 7QG, United Kingdom. Registered in England.
VAT number: GB320549229